FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae

Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Updated Information

FDA approves 1st drug for children 7 years and older with irritable bowel syndrome with constipation

Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/23/2020
Short Title (70 char) Frank Steven Eder, MD. Binghamton NY. EIR issued 11/23/2020
FEI Number 3006983127
Firm Name Frank Steven Eder, MD
Record Type EIR
State FL
Establishment Type Clinical Investigat

Guidance documents represent the FDA’s current thinking on a particular subject. New guidance documents are listed here for three months.

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet

Unapproved New Drugs/Adulterated/Misbranded